ArticleHealth economics review2018
Worldwide assessment of healthcare personnel dealing with lymphoedema.
Article in Health economics review, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.
- Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.Frontiers in oncology · 2025Pooled it
- Systematic Review of Magnetic Resonance Lymphangiography From a Technical Perspective.Journal of magnetic resonance imaging : JMRI · 2021Pooled it
- Self-administered versus lymphedema therapist-administered complex decongestive therapy protocol in breast cancer-related lymphedema: a non-inferiority randomized controlled trial with three-month follow-up.Breast cancer research and treatment · 2025Trial
- Racial and ethnic disparities in T helper 2-mediated inflammatory skin disorders.Skin health and disease · 2026Review
- "Do I buy my children shoes, or do I get a compression garment for my lymphoedema?" Australian stakeholder perspectives on cancer-related lymphoedema care.Journal of cancer survivorship : research and practice · 2026Article
- "Debulking" the future of lymphedema surgery: A narrative review.JPRAS open · 2026Review
- A biomimetic anthropomorphic leg phantom for wearable bioimpedance sensing in lymphedema monitoring.Journal of electrical bioimpedance · 2026Article
- Histone modifications in skin fibrosis: linking immune dysregulation, metabolic reprogramming, and persistent fibrotic remodeling.Frontiers in immunology · 2026Review
- Women's and practitioners' views of early intensive decongestive lymphoedema treatment for breast cancer-related arm lymphoedema: a focus group study.Journal of cancer survivorship : research and practice · 2025Article
- Review
- Men's Perceptions of Non-Cancer Related Lymphoedema: A Qualitative Diary Study.Nursing & health sciences · 2025Article
- Article
- Bridging the Knowledge Gap: Assessing Healthcare Professionals' Learning Outcomes After Establishing a Lymphedema Management Conference.Plastic and reconstructive surgery. Global open · 2025Article
- [An overview of integrated surgical management for secondary lower limb lymphedema guided by algorithms].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2025Article
- Comfortable knowing little about lymphoedema? A qualitative study of medical interns in Australia.BMJ open · 2025Article
- Tissue engineering approaches for lymphedema: biomaterial innovations and clinical potential.Frontiers in cell and developmental biology · 2025Review
- Improved lymphangiogenesis around vascularized lymph node flaps by periodic injection of hyaluronidase in a rodent model.Scientific reports · 2024Article
- Surgical management of lymphedema: prophylactic and therapeutic operations.Current breast cancer reports · 2024Article
- Trends in Immediate Lymphatic Reconstruction.Cureus · 2024Article
- Topical tissue nanotransfection ofMolecular therapy. Nucleic acids · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
Abstract
backgroundLymphoedema is a pandemic with about 250 million people suffering from this condition worldwide. Lymphatic diseases have considerable public health significance, but yet few professionals are specialised in their management causing a substantial burden on health resources. AIMS AND
objectivesThis study aims to give an overview of the approximate number of medical professionals, professional societies, institutions and companies dealing with lymphoedema in various countries. Concepts of improvement for current human resources are considered.
methodsAn online database analysis (Google search engine and PubMed) was carried out for each country of the world. Additionally, relevant congress participant lists as well as member lists of significant medical societies and reports of the World Health Organisation were analysed.
resultsOverall distribution of tertiary level professionals specialised in this field is heterogenous. A decrescent gradient of professionals can be seen between developed and developing countries and between urban and rural areas. Countries in general do not seem to have yet met the current demand for specialists at tertiary level in this field.
conclusionsThis study intends to draw attention to the current medical coverage gaps due to a low number of lymphoedema specialists at tertiary level. It wishes to start a discussion about structured reimbursement and certification of knowledge and skills that are essential incentives for experts to act as multiplicators and change the lack of care in the mid-term. Current fail prescriptions and evitable disability and sick certificates represent a high financial burden that could be reinvested in a correct management. Policy makers must focus in the two above mentioned essential measures. Medical training and the consequent development of the industry will then naturally take place, as it was the case for other professional groups in the past.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.